AbbVie, Inc. (ABBV)
Live and historical stock data for AbbVie, Inc., delivered through Axion's financial data API - pricing, fundamentals, SEC filings, ownership, ETF exposure and sentiment in one JSON response.
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; V…
GET /stocks/ABBV/pricesABBV Price History
Weekly close prices for AbbVie, Inc., pulled directly from Axion's historical market data API.
ABBV Fundamentals - Financial Analytics API
Multi-year AbbVie, Inc. financial statement data, structured for a quantitative finance API workflow - no PDF parsing or scraping required.
GET /financials/ABBV/revenueRevenue & Net Income
Annual revenue vs. net income, sourced from SEC filings.
- Net Income
- Revenue
GET /financials/ABBV/cashflow/freeFree Cash Flow vs. CapEx
Cash generated after operating costs vs. capital reinvested into the business.
- CapEx
- Free Cash Flow
GET /financials/ABBV/epsEPS Trend (TTM)
Trailing twelve-month earnings per share, by report date.
GET /financials/ABBV/roe · /deProfitability & Leverage
Return on equity vs. debt-to-equity, by report date.
- Debt/Equity
- ROE
ABBV Valuation - Investment Research API
DCF fair value, analyst consensus and the 52-week trading range for ABBV, built for investment research API and trading data API use cases.
GET /financials/dcf/ABBV/valueMargin of safety: 0.8%
GET /profiles/ABBV/summary52W Range: $184.39 - $255.99
GET /profiles/ABBV/recommendationAnalyst Consensus Trend
Strong buy / buy / hold / sell counts across recent trailing periods.
- Buy
- Hold
- Sell
- Strong Buy
ETF & Fund Exposure to ABBV
Every mutual fund and ETF reporting a position in ABBV, searchable by fund name - a direct look at institutional financial data API coverage for this ticker.
GET /insiders/ABBV/funds| Fund / ETF | Shares Held | % Held | Value |
|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | - | 3.2% | $14.13B |
| VANGUARD INDEX FUNDS-Vanguard 500 Index Fund | - | 2.5% | $11.30B |
| iShares Trust-iShares Core S&P 500 ETF | - | 1.3% | $5.75B |
| Fidelity Concord Street Trust-Fidelity 500 Index Fund | - | 1.3% | $5.69B |
| SPDR S&P 500 ETF TRUST-State Street SPDR S&P 500 ETF Trust | - | 1.2% | $5.36B |
| VANGUARD INDEX FUNDS-Vanguard Value Index Fund | - | 0.9% | $4.12B |
| SCHWAB STRATEGIC TRUST-Schwab US Dividend Equity ETF | - | 0.7% | $3.29B |
| SELECT SECTOR SPDR TRT-State Street Health Care Select Sector SPDR ETF | - | 0.7% | $3.09B |
| AMERICAN MUTUAL FUND | - | 0.6% | $2.76B |
| VANGUARD INSTITUTIONAL INDEX FUNDS-Vanguard Institutional Index Fund | - | 0.6% | $2.51B |
Companies Linked to ABBV - Trading Data API
Peers, suppliers and customers mapped from Axion's supply chain API, useful for building correlated, cross-company trading data API signals.
- Abbvie IncABBV
- Certara IncCERT
- Veeva Systems IncVEEV
- Avery Dennison CorporationAVY
- Darling Ingredients IncDAR
- Stericycle IncSRCL
- Abbvie IncABBV
- Aflac IncorporatedAFL
- Assurant IncAIZ
- Axis Capital Holdings LimitedAXS
- The Cigna GroupCI
- Centene CorporationCNC
- Tenaya Therapeutics, Inc.TNYA
- Biomea Fusion IncBMEA
- CNS Pharmaceuticals, Inc.CNSP
- NanoViricides, Inc.NNVC
- Genprex IncGNPX
- Neumora Therapeutics, Inc.NMRA
ABBV Ownership - Institutional Financial Data API
Insider, institutional and public ownership breakdown, plus the latest insider transactions.
GET /insiders/ABBV/ownership- Insiders
- Institutions
- Public / Other
| Insider | Activity | Shares | Value |
|---|---|---|---|
| FREYMAN THOMAS C | Stock Award(Grant) at price 0.00 per share. | 1.1K | $0.00 |
| FALK THOMAS J | Stock Award(Grant) at price 0.00 per share. | 1.1K | $0.00 |
| AUSTIN ROXANNE SCHUH | Stock Award(Grant) at price 0.00 per share. | 1.1K | $0.00 |
| BURNSIDE WILLIAM H L | Stock Award(Grant) at price 0.00 per share. | 1.1K | $0.00 |
| MEYER MELODY B | Stock Award(Grant) at price 0.00 per share. | 1.1K | $0.00 |
ABBV ESG Scores
Environmental, social, governance and controversy scores, pulled from the same financial data API.
GET /esg/ABBVESG Score Breakdown
ABBV Market Sentiment - Financial Intelligence API
News, social and analyst sentiment for ABBV, refreshed continuously.
GET /sentiment/ABBV/newsGET /sentiment/ABBV/socialGET /sentiment/ABBV/analystGET /filings/ABBVRecent SEC Filings
- 424B5Aug 6, 2026
- 8-KAug 5, 2026
- FWPAug 5, 2026
- 424B5Aug 4, 2026
- 10-QAug 3, 2026
GET /news/ABBVLatest News
- Could AbbVie Inc. (ABBV) Win as Genmab A/S (GMAB) Faces a New Regulatory Test for Epcoritamab? - Yahoo Finance Thu, 13 Aug 2026 23:38:35 GMT
- Thomasville National Bank Buys Shares of 26,575 AbbVie Inc. $ABBV - MarketBeat Fri, 14 Aug 2026 10:23:40 GMT
- Could AbbVie Inc. (ABBV)’s Post-Humira Transformation Drive the Next Phase of Growth? - Yahoo Finance Thu, 13 Aug 2026 21:33:06 GMT
- AbbVie, Novartis Seek Block Illinois 340B Drug Discount Law - Law360 Tue, 11 Aug 2026 01:07:00 GMT
- Is AbbVie Stock a Buy After Posting Strong Q2 Earnings? - The Motley Fool Mon, 10 Aug 2026 14:44:00 GMT
See It In Action - API & Python Example
The same request that powers this page, in cURL, Python and JavaScript, plus an example chart rendered straight from the response.
curl https://api.axionquant.com/stocks/ABBV/quote \
-H "Authorization: Bearer YOUR_API_KEY"GET /financials/ABBV/revenueRendered from the response above
Revenue vs. net income - the exact data returned by the Python example.
- Historical prices (OHLCV)
- Financial statements & ratios
- DCF valuation & analyst consensus
- Insider & institutional ownership
- ETF & fund exposure
- ESG scores
- Supply chain & peers
- SEC filings
- News, social & analyst sentiment
- Company news
Why Developers Use Axion's Financial Data API
A single stock market API and market data API for pricing, fundamentals and alternative data - built for quant research API and institutional financial data API workflows.
One API, every asset class
Equities, ETFs, crypto, forex and futures through a single financial data API - no juggling vendors.
Institutional-grade fundamentals
Point-in-time financial statements sourced from SEC filings, built for an institutional financial data API workflow.
Built for backtesting
Daily and weekly historical market data going back years, ready for a quantitative finance API pipeline.
Alternative data included
ESG, sentiment, supply chain and insider activity - a financial intelligence API that goes beyond price.
Free tier, real docs
Explore the stock data API for free - grab a key and start pulling market data in minutes.
Research You Can Build on ABBV
Starting points for quant research API and investment research API projects using this ticker.
Backtest a strategy on ABBV
Pull ABBV's full daily price history and combine it with fundamentals to backtest momentum or mean-reversion signals.
Build a DCF valuation model
Feed live revenue, free cash flow and discount-rate inputs into your own model, benchmarked against Axion's DCF fair value.
Screen for Health Technology peers
Use supply-chain and sector classification data to build a comparable-company screen around ABBV.
Factor in ESG and sentiment
Combine ESG scores with news and social sentiment to test alternative-data factors against returns.
Track insider conviction
Monitor insider buying and selling activity, plus ETF and institutional ownership shifts, ahead of catalysts.
Map supply-chain risk
Trace ABBV's suppliers and customers to model second-order exposure to sector shocks.
Explore More From Axion
One account, every dataset - browse the rest of Axion's market data API and alternative data catalog.
Built for Teams Like These
From independent researchers to institutional desks - Axion powers financial applications at every scale.
ABBV Data, Built for Developers and Quant Teams
AbbVie, Inc. pricing, fundamentals and alternative data are available through Axion's financial data API - a single, consistent stock data API and market data API covering equities, ETFs, crypto, forex and futures. Instead of stitching together a stock market API for pricing, a separate SEC filings feed, and a spreadsheet for fundamentals, pull ABBV's revenue, EPS, insider activity, ETF exposure, ESG scores and DCF valuation from one financial analytics API.
Axion is built for institutional financial data API and quant research API workflows: point-in-time financial statements for backtesting, a historical market data API with daily and weekly granularity going back years, and an investment research API layer that surfaces analyst consensus, sentiment and ownership changes for ABBV alongside every other ticker you track. Whether you're building a quantitative finance API pipeline, a trading data API for a systematic strategy, or a research dashboard, ABBV's complete dataset is one authenticated request away.
Frequently asked questions
Does Axion offer a stock market API for ABBV?
Yes. Axion's stock data API returns real-time quotes, historical prices, fundamentals, SEC filings, ownership and sentiment for ABBV through a single financial data API key.
Can I pull ABBV's historical market data programmatically?
Yes - the historical market data API returns daily, weekly, monthly, quarterly or yearly OHLCV bars for ABBV, with no fixed lookback limit.
Is ABBV's fundamental data suitable for quant research?
Yes. Revenue, net income, free cash flow, ROE and DCF valuation are exposed as structured JSON, ready for a quantitative finance API or quant research API pipeline - no scraping or PDF parsing required.
Can I see which ETFs and funds hold ABBV?
Yes. Axion's institutional financial data API includes fund and ETF ownership, insider transactions and major-holder breakdowns for ABBV, refreshed alongside SEC filings.